join fridays tirzepatide No crash diets. No gimmicks. MAX results. Trusted GLP medication, right to your door My honest review of the

Surgery vs GLP1s at a glance What this means if you are considering the treatment The JAMA Surgery research confirms that bariatric surgery stands as a primary treatment choice for patients with class II and III obesity because it produces superior and enduring weight loss results

Personalized Care: Every participant receives a one-on-one consultation with a medical provider to build a plan tailored to your unique needs and lifestyle

L.MisumiM.CullingsH

One clinical trial gave Wegovy to obese, non-diabetic patients for 68 weeks

Instead of being described as a dual GIP and GLP-1 receptor agonist like Tirzepatide, Retatrutide is commonly described as a triple hormone receptor agonist

This dual action helps you achieve better glycemic control and facilitates weight loss